Ethel Rubin, Ph. D.

Entrepreneur-in-Residence
Ethel Rubin, Ph. D.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Dr. Ethel Rubin comes to us with a history of accomplishments in the medical device, corporate ventures and translational medicine industry. Most recently, Dr. Rubin oversaw global investments in commercially strategic studies for Medtronic’s catheter ablation business, following leadership roles in clinical strategy and medical affairs for Medtronic CRDM. She has consulted for VCs and other corporate clients, taking the lead on due diligence for investment and M&A efforts through her consulting firm, Innovative BioStrategies, LLC. Ethel was previously Chief Scientific Officer of two Maryland companies, CSA Medical, Inc. and BioFortis, Inc, where she played a key role in technology development and commercialization efforts. A cell and molecular scientist by training, Dr. Rubin's research at The Johns Hopkins School of Medicine Sidney Kimmel Comprehensive Cancer Center elucidated pathways for potential intervention in breast cancer. She earned a PhD in Biochemistry and Biophysics from the University of Rochester School of Medicine and Dentistry and has held business leadership roles in many organizations, including Women In Bio, MIDC, GBTC BioTech Roundtable and the Emerging Technology Center incubator, among others.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Located in: Staff
Powered by SobiPro